Day: Healthtech
7 Questions
Rnatics: Hope for pulmonary fibrosis
Rnatics is developing RCS-21, a novel inhalable drug for pneumonia and idiopathic pulmonary fibrosis. The startup was founded in 2021 as a spin-off of…
Deals
Tubules purchased from American pharmaceutical giant
Munich-based biotech unicorn Tubulis is being sold to US corporation Gilead for a billion-dollar sum.
7 Questions
Rnhale: Inhalable RNA for new therapies
Munich-based biotech startup Rnhale is developing inhalable RNA therapeutics as a dry powder – faster, simpler, and more efficient than previous approaches. This is intended to treat respiratory diseases…
7 Questions
Mpiriq: AI connects healthcare and research
Mpiriq connects medical care and research using artificial intelligence. The platform structures data from medical practices and clinics, automates documentation, and…
Deals
SAP invests in Avelios Medical
Munich-based software provider Avelios Medical has received a strategic investment from SAP. Together, the partners are developing a new digital platform for…
Deals
A milestone in the treatment of lung diseases? Rnatics receives 2.7 million euros.
Munich-based biotech startup Rnatics has secured €2.7 million in federal funding. The funds will be used for the clinical development of a…
Deals
Custom Surgical raises money for the digitalization of ophthalmology
Munich-based medtech startup Custom Surgical has secured €3.5 million in funding from Ventech, Zeiss, and other investors. This pre-Series A funding round will accelerate the company's growth…
7 Questions
Smartbax: New antibiotics against superbugs
Smartbax develops innovative antibiotics against multi-resistant bacteria with a completely new mechanism of action: Instead of blocking processes, they cause germs to…
Deals
Bodyfast secures strategic investment
Munich-based healthtech company Bodyfast has gained its first strategic investor in Isartal Health Media. The investment comes from the Wort & Bild publishing group…
7 Questions
Cellbyte: AI accelerates market access for pharmaceuticals
Cellbyte aims to revolutionize the global market launch of pharmaceuticals: With an AI-native platform, the Munich-based startup automates pricing and market access processes in…
Deals
Amplifold raises 5 million euros
Munich-based startup Amplifold receives five million euros for the further development of its DNA origami technology, which is intended to make rapid medical tests significantly more sensitive.
Deals
Tubulis receives record sum of 308 million euros
Munich-based biotech Tubulis is working on special antibody drug conjugates (ADCs) for cancer therapy. The company has now secured €308 million in funding…
